{"id":"W2150451787","doi":"10.1111/dme.12243","title":"Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN<sup>®</sup> Basal–Bolus Type 1): 2‐year results of a randomized clinical trial","year":2013,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Diabetes Management and Research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novo Nordisk; Johnson and Johnson; Canadian Diabetes Association; Diabetes Canada; Eli Lilly and Company","keywords":"Insulin degludec; Insulin glargine; Medicine; Insulin aspart; Insulin; Internal medicine; Endocrinology; Diabetes mellitus; Type 2 diabetes; Basal (medicine); Type 1 diabetes; Hypoglycemia","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00249246,0.0009690408,0.001910682,0.0003156535,0.0002382694,0.001243655,0.0005988685,0.001240811,0.003391092],"category_scores_gemma":[0.001911272,0.0004885703,0.00190521,0.0003573593,0.0006966004,0.0008151439,0.0002914398,0.002054282,0.0003204168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005013898,"about_ca_system_score_gemma":0.0005868107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004081542,"about_ca_topic_score_gemma":0.0008257858,"domain_scores_codex":[0.9990548,0.0005784846,0.00008557062,0.0001242246,0.00006226207,0.0000946774],"domain_scores_gemma":[0.9986614,0.0005103495,0.0003861153,0.000113633,0.00005621955,0.0002722921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9734809,0.007529639,0.001087277,0.0003467329,0.0007570017,0.00002192354,0.0000266937,0.0001557577,0.002045822,0.00003184712,0.0001824563,0.01433404],"study_design_scores_gemma":[0.8463886,0.1456548,0.00590658,0.00004096429,0.0006401018,0.0000464954,0.0000173649,0.0003594068,0.0006058632,0.00005078658,0.0002766877,0.00001221522],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948008,0.003344519,0.000202436,0.0001779623,0.0002122239,0.0005434082,0.0001618146,0.00003091264,0.0005258048],"genre_scores_gemma":[0.9944112,0.002151088,0.0009012618,0.0004521972,0.0003899999,0.0005807065,0.0004197535,0.000009979921,0.0006837267],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003391092,"threshold_uncertainty_score":0.01318151,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02044180789382148,"score_gpt":0.2916100930684961,"score_spread":0.2711682851746746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}